Asia IPO round-up: HK, US and India listings coming up

Rashmi Kumar

November 04, 2019 06:15 AM

NYSE_stocks__PA_230x150

Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Deutsche Bank Credit Suisse Equity IPOs UBS Equity China Americas Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific North America DBS Morgan Stanley BNP Paribas United States Emerging Markets

RK

Rashmi Kumar